Mycosis Fungoides

Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides

Photopheresis in Early-stage Mycosis Fungoides

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

A Study of VG712 in Patients With Mycosis Fungoides

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome

Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients